Indication
Female hypogonadism
Female hypogonadism is an endocrine disorder characterized by deficient ovarian function, resulting in insufficient production of sex steroids, predominantly estradiol, and impaired oocyte maturation. Read more about Female hypogonadism
70 drugs 47 manufacturers
Drugs that treat it
Common Female hypogonadism therapies.
ESTRADIOL
ESTRADIOL (TWICE WEEKLY) (estradiol)
ESTRADIOL VALERATE
ESTRADIOL (ONCE WEEKLY) (estradiol)
ESTRADIOL (TWICE WEEKLY) (estradiol)
ESTRADIOL VALERATE
ESTRADIOL VALERATE
VIVELLE-DOT (estradiol)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonFemale hypogonadism is an endocrine disorder characterized by deficient ovarian function, resulting in insufficient production of sex steroids, predominantly estradiol, and impaired oocyte maturation.
It affects female reproductive physiology across various life stages and can originate from intrinsic ovarian dysfunction, termed hypergonadotropic or primary hypogonadism, or from hypothalamic-pituitary axis failure, termed hypogonadotropic or secondary hypogonadism.
Clinically, it manifests as delayed or absent pubertal development in adolescents, and as oligomenorrhea, amenorrhea, infertility, vasomotor symptoms, and accelerated bone mineral density loss in reproductive-age and adult women.
- nih.gov
Female hypogonadism is an endocrine disorder characterized by deficient ovarian function, resulting in insufficient production of sex steroids, predominantly estradiol, and impaired oocyte maturation It affects female reproductive physiology across various life stages and can originate from intrinsic ovarian dysfunction, termed hypergonadotropic or primary hypogonadism, or from hypothalamic-pituitary axis failure, termed hypogonadotropic or secondary hypogonadism Clinically, it manifests as dela...
- dermnetnz.org
Female hypogonadism is an endocrine disorder characterized by deficient ovarian function, resulting in insufficient production of sex steroids, predominantly estradiol, and impaired oocyte maturation It affects female reproductive physiology across various life stages and can originate from intrinsic ovarian dysfunction, termed hypergonadotropic or primary hypogonadism, or from hypothalamic-pituitary axis failure, termed hypogonadotropic or secondary hypogonadism
- bodyspec.com
Female hypogonadism is an endocrine disorder characterized by deficient ovarian function, resulting in insufficient production of sex steroids, predominantly estradiol, and impaired oocyte maturation Clinically, it manifests as delayed or absent pubertal development in adolescents, and as oligomenorrhea, amenorrhea, infertility, vasomotor symptoms, and accelerated bone mineral density loss in reproductive-age and adult women
- nih.gov
Clinically, it manifests as delayed or absent pubertal development in adolescents, and as oligomenorrhea, amenorrhea, infertility, vasomotor symptoms, and accelerated bone mineral density loss in reproductive-age and adult women
- ucsf.edu
Clinically, it manifests as delayed or absent pubertal development in adolescents, and as oligomenorrhea, amenorrhea, infertility, vasomotor symptoms, and accelerated bone mineral density loss in reproductive-age and adult women
Personalize your experience
Follow Female hypogonadism and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.